These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16936711

  • 1. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
    Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, DeVane CL.
    Neuropsychopharmacology; 2007 Apr; 32(4):757-64. PubMed ID: 16936711
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
    Wang JS, Zhu HJ, Markowitz JS, Donovan JL, DeVane CL.
    Psychopharmacology (Berl); 2006 Sep; 187(4):415-23. PubMed ID: 16810505
    [Abstract] [Full Text] [Related]

  • 3. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL.
    J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
    [Abstract] [Full Text] [Related]

  • 4. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
    Yang ZH, Liu XD.
    Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells.
    Zhu CJ, Hua F, Zhu XL, Li M, Wang HX, Yu XM, Li Y.
    PLoS One; 2015 Jan; 10(8):e0135866. PubMed ID: 26295572
    [Abstract] [Full Text] [Related]

  • 6. Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
    Inoue T, Osada K, Tagawa M, Ogawa Y, Haga T, Sogame Y, Hashizume T, Watanabe T, Taguchi A, Katsumata T, Yabuki M, Yamaguchi N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):156-62. PubMed ID: 22691713
    [Abstract] [Full Text] [Related]

  • 7. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
    Cho HJ, Choi MK, Lin H, Kim JS, Chung SJ, Shim CK, Kim DD.
    J Pharm Pharmacol; 2011 Mar 01; 63(3):385-91. PubMed ID: 21749386
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L, Zhao C, Yan M, Zhang LY, Xia YZ.
    Phytother Res; 2009 Jul 01; 23(7):933-7. PubMed ID: 19172664
    [Abstract] [Full Text] [Related]

  • 9. The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study.
    Watanabe N, Higashi H, Nakamura S, Nomura K, Adachi Y, Taguchi M.
    Biopharm Drug Dispos; 2018 Jan 01; 39(1):30-37. PubMed ID: 29055041
    [Abstract] [Full Text] [Related]

  • 10. Interaction of imatinib mesilate with human P-glycoprotein.
    Hamada A, Miyano H, Watanabe H, Saito H.
    J Pharmacol Exp Ther; 2003 Nov 01; 307(2):824-8. PubMed ID: 12975485
    [Abstract] [Full Text] [Related]

  • 11. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM.
    J Pharm Pharm Sci; 2007 Nov 01; 10(3):319-31. PubMed ID: 17727795
    [Abstract] [Full Text] [Related]

  • 12. Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.
    Perloff ES, Duan SX, Skolnik PR, Greenblatt DJ, von Moltke LL.
    Drug Metab Dispos; 2005 Jun 01; 33(6):764-70. PubMed ID: 15764714
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methadone inhibits rhodamine123 transport in Caco-2 cells.
    Störmer E, Perloff MD, von Moltke LL, Greenblatt DJ.
    Drug Metab Dispos; 2001 Jul 01; 29(7):954-6. PubMed ID: 11408360
    [Abstract] [Full Text] [Related]

  • 15. Real-time analysis of P-glycoprotein-mediated drug transport across primary intestinal epithelium three-dimensionally cultured in vitro.
    Mizutani T, Nakamura T, Morikawa R, Fukuda M, Mochizuki W, Yamauchi Y, Nozaki K, Yui S, Nemoto Y, Nagaishi T, Okamoto R, Tsuchiya K, Watanabe M.
    Biochem Biophys Res Commun; 2012 Mar 09; 419(2):238-43. PubMed ID: 22342245
    [Abstract] [Full Text] [Related]

  • 16. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep 09; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 17. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
    Sugimoto H, Hirabayashi H, Kimura Y, Furuta A, Amano N, Moriwaki T.
    Drug Metab Dispos; 2011 Jan 09; 39(1):8-14. PubMed ID: 20962062
    [Abstract] [Full Text] [Related]

  • 18. Effects of P-glycoprotein inhibitors on transepithelial transport of cadmium in cultured renal epithelial cells, LLC-PK1 and LLC-GA5-COL 150.
    Kimura O, Endo T, Hotta Y, Sakata M.
    Toxicology; 2005 Mar 01; 208(1):123-32. PubMed ID: 15664439
    [Abstract] [Full Text] [Related]

  • 19. P-glycoprotein interaction with risperidone and 9-OH-risperidone studied in vitro, in knock-out mice and in drug-drug interaction experiments.
    Ejsing TB, Pedersen AD, Linnet K.
    Hum Psychopharmacol; 2005 Oct 01; 20(7):493-500. PubMed ID: 16118767
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
    Yoshida N, Koizumi M, Adachi I, Kawakami J.
    Food Chem Toxicol; 2006 Dec 01; 44(12):2033-9. PubMed ID: 16904803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.